PT  - JOURNAL ARTICLE
AU  - Néstor Gabriel Iglesias
AU  - Leopoldo Germán Gebhard
AU  - Juan Manuel Carballeda
AU  - Ignacio Aiello
AU  - Emiliano Recalde
AU  - Gabriel Terny
AU  - Silvina Ambrosolio
AU  - Gabriela L’Arco
AU  - Jonatan Konfino
AU  - Juan Ignacio Brardinelli
TI  - SARS-CoV-2 surveillance in untreated wastewater: first detection in a low-resource community in Buenos Aires, Argentina
AID  - 10.1101/2020.10.21.20215434
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.21.20215434
4099  - http://medrxiv.org/content/early/2020/10/25/2020.10.21.20215434.short
4100  - http://medrxiv.org/content/early/2020/10/25/2020.10.21.20215434.full
AB  - Recently, the World Health Organization (WHO) in a brief report about the status of environmental surveillance for SARS-CoV-2 indicated that approaches are needed that can be applied in lower-resource settings, where a greater proportion of the population is not connected to sewers and instead uses pit toilets or septic tanks. Possibilities include testing surface water contaminated by sewage. In this study we measured SARS-CoV-2 RNA from a surface water source in a low-income settlement. We observe for this community that measurements of SARS-CoV-2 concentrations in surface water contaminated by sewage can be considered as an estimation of changes in COVID-19 prevalence on a population level.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: Programa de articulacion y fortalecimiento federal de las capacidades en Ciencia y Tecnologia COVID-19, from the Ministry of Science, Technology and Innovation of Argentina. Acknowledgements: We wish to thank the OPDS laboratory staff for the sampling task and Carolina Vera from the Ministry of Science, Technology and Innovation of Argentina for her support to the project. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No oversight was requiredAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data is given in the manuscript